4//SEC Filing
Douglas Earl Martin 4
Accession 0001593968-24-001096
CIK 0001737287other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 4:15 PM ET
Size
8.5 KB
Accession
0001593968-24-001096
Insider Transaction Report
Form 4
Douglas Earl Martin
SVP, General Counsel
Transactions
- Tax Payment
Common Stock
2024-08-21$2.79/sh−28,310$78,843→ 449,324 total
Footnotes (2)
- [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001362155
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 4:15 PM ET
- Size
- 8.5 KB